GlassScriptPhysician profile
Steven L Hamilton
NPI 1972897171
$28,002.86
in general payments reported to CMS, 2019-2025
19 companies · $4,991 in 2025
The $4,991 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,111 · 2020: $1,381 · 2021: $1,015 · 2022: $5,207 · 2023: $4,948 · 2024: $9,351 · 2025: $4,991.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,529 · Travel and Lodging: $6,386 · Consulting Fee: $3,375.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,528.71 |
| Travel and Lodging | $6,386.10 |
| Consulting Fee | $3,375.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $9,390.99 | 2021-2025 | Evera Mri Xt Dr Surescan, Micra, Cobalt Dr Mri Surescan |
| Biosense Webster, INC. | $5,815.11 | 2019-2025 | Carto 3, Nuvision Ice Catheter |
| Boston Scientific Corporation | $5,207.72 | 2021-2025 | Watchman Flx, Farapulse, Watchman |
| Abbott Laboratories | $5,060.94 | 2019-2025 | Aveir, Ensite, Advisor |
| Medtronic Vascular, INC. | $1,173.06 | 2019-2020 | |
| Medical Device Business Services, INC. | $342.94 | 2019 | |
| Abiomed | $219.94 | 2023-2025 | Impella |
| Atricure, INC. | $174.19 | 2023 | |
| Stereotaxis INC | $127.16 | 2020-2023 | Niobe |
| Philips North America LLC | $124.80 | 2019-2024 | (Am5) Lead Management |
| E.R. Squibb & Sons, L.L.C. | $67.30 | 2022-2023 | Camzyos, Eliquis |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $60.15 | 2021-2025 | Lifevest |
| Shockwave Medical, INC | $54.36 | 2025 | |
| Janssen Pharmaceuticals, INC | $49.43 | 2019-2020 | |
| Pfizer INC. | $40.41 | 2022-2024 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Haemonetics Corporation | $26.78 | 2024 | Ensoetm |
| Zoll Respicardia, INC. | $25.93 | 2023 | Remede System |
| Amgen INC. | $23.51 | 2020 | |
| Alnylam Pharmaceuticals INC. | $18.14 | 2024 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Hamilton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.